CCRL2 and hematologic disorder: This is consistent with prior studies showing CCRL2’s interaction with TLR4 in macrophages, enhancing its stability and supporting NF-κB activation, and its involvement in IFN-γ/STAT1 signaling in hematologic malignancies, even in the absence of exogenous cytokine.